Cardinal Health: Set to Beat - Analyst Blog

By
A A A

We expect Cardinal Health ( CAH ) to beat expectations when it reports fiscal second quarter 2013 results on Feb 5. 

Why a Likely Positive Surprise?

Our proven model shows that Cardinal Health is likely to beat earnings because it has the right combination of two key ingredients.

Positive Zacks ESP: Earnings Expected Surprise Prediction or ESP (Read: Zacks Earnings ESP: A Better Method ), which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is at +1.2%. This is a meaningful and leading indicator of a likely positive earnings surprise for shares.

Zacks Rank #3 (Hold): Note that stocks with Zacks Ranks of #1, 2 and 3 have a significantly higher chance of beating earnings. The sell rated stocks (#4 and 5) should never be considered going into an earnings announcement.

The combination of Cardinal Health's Zacks Rank #3 (Hold) and Earnings ESP of +1.2% makes us confident of a positive earnings beat this coming announcement.

What is Driving the Better than Expected Earnings?

The company stands to gain from the gradual shift in mix from bulk to the higher-margin non-bulk sector of the Pharmaceutical segment. It is also riding the generic wave. Overall, Cardinal benefits from a spate of tuck-in acquisitions and capital deployment strategies. The positive trend is seen in the trailing four-quarter average surprise of 4.3%.

Other Stocks to Consider

Cardinal Health is not the only stock looking up this earnings season. We also see likely earnings beats coming from these three players.

ResMed ( RMD ) has earnings ESP of +3.6% and Zacks Rank #1 (Strong Buy).

Cyberonics ( CYBX ) has earnings ESP of +2.6% and Zacks Rank #1 (Strong Buy).

Becton, Dickinson and Company ( BDX ) has earnings ESP of +3.3% and Zacks Rank #2 (Buy).



BECTON DICKINSO (BDX): Free Stock Analysis Report

CARDINAL HEALTH (CAH): Free Stock Analysis Report

CYBERONICS INC (CYBX): Free Stock Analysis Report

RESMED INC (RMD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: BDX , CAH , CYBX , RMD

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

89,865,296
  • $16.21 ▲ 0.81%
75,109,464
  • $2.72 ▲ 3.03%
66,341,418
  • $97.67 ▲ 1.46%
62,511,232
  • $93 ▲ 1.32%
61,561,006
  • $75.95 ▲ 4.57%
57,374,027
  • $3.21 ▲ 69.84%
49,928,586
  • $24.82 ▲ 2.35%
39,880,670
  • $43.63 ▲ 2.08%
As of 10/17/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com